Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Schroeder, J. Hung, I. Lamb, S. Connolly, K. Jutzy, M. Goris (2009)
Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.Acta pharmacologica et toxicologica, 57 Suppl 2
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Hypertension, 42 6
S. Ulimoen, S. Enger, J. Carlson, P. Platonov, A. Pripp, M. Abdelnoor, H. Arnesen, K. Gjesdal, A. Tveit (2013)
Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.The American journal of cardiology, 111 2
S. Yeh, H. Kou, Fun-Chung Lin, J. Hung, Delon Wu (1983)
Effects of oral diltiazem in paroxysmal supraventricular tachycardia.The American journal of cardiology, 52 3
J. Hung, I. Lamb, S. Connolly, K. Jutzy, M. Goris, J. Schroeder (1983)
The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.Circulation, 68 3
L. Hansson, T. Hedner, P. Lund-johansen, S. Kjeldsen, L. Lindholm, J. Syvertsen, J. Lanke, U. Faire, B. Dahlöf, B. Karlberg (2000)
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) studyThe Lancet, 356
H. Doğan, D. Ozucelik, K. Aciksari, I. Cağlar, Nursel Okutan, M. Yazıcıoğlu, Baris Avyaci, C. Şimşek, Derya Ozasir, T. Gi̇ray, Cem Ayan, F. Celikmen, Y. Okuturlar, Sezgin Sarıkaya (2015)
To decide medical therapy according to ECG criteria in patients with supraventricular tachycardia in emergency department: adenosine or diltiazem.International journal of clinical and experimental medicine, 8 6
P. Deedwania, P. Pool, U. Thadani, J. Eff (1997)
Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.The American journal of cardiology, 80 4
G. Mancia, G. Backer, A. Dominiczak, R. Cífková, R. Fagard, G. Germano, G. Grassi, A. Heagerty, S. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R. Schmieder, H. Boudier, A. Zanchetti (2007)
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Journal of Hypertension, 25
W. Graney (1992)
Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.The American journal of medicine, 93 2A
P. Alboni, C. Tomasi, C. Menozzi, N. Bottoni, N. Paparella, G. Fucà, M. Brignole, Riccardo Cappato (2001)
Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.Journal of the American College of Cardiology, 37 2
D. Abernethy, J. Schwartz (1999)
Calcium-antagonist drugs.The New England journal of medicine, 341 19
Steven Claas, S. Glasser (2005)
Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectorisExpert Opinion on Pharmacotherapy, 6
(American Heart Association. http://www.heart.org. Accessed Feb 3, 2016.)
American Heart Association. http://www.heart.org. Accessed Feb 3, 2016.American Heart Association. http://www.heart.org. Accessed Feb 3, 2016., American Heart Association. http://www.heart.org. Accessed Feb 3, 2016.
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA, 289 19
K. Ellenbogen, V. Dias, F. Cardello, W. Strauss, C. Simonton, S. Pollak, M. Wood, B. Stambler (1995)
Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.The American journal of cardiology, 75 1
(2009)
Supraventricular tachycardiaMed J Aust, 190
J. Hung, S. Yeh, F. Lin, M. Fu, Y. Lee, D. Wu (1984)
Usefulness of intravenous diltiazem in predicting subsequent electrophysiologic and clinical responses to oral diltiazem.The American journal of cardiology, 54 10
G. Mancia, R. Fagard, K. Narkiewicz, Josep Redán, A. Zanchetti, Michael Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, Tiny Jaarsma, Paulus Kirchof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, Peter Sleight, M. Viigimaa, Bernard Waeber, F. Zannad (2013)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.Journal of hypertension, 31 10
A. Roth, E. Harrison, G. Mitani, J. Cohen, S. Rahimtoola, U. Elkayam (1986)
Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.Circulation, 73 2
(Drugs.com. Diltiazem. http://www.drugs.com/pro/diltiazem.html. Accessed Feb 3, 2016.)
Drugs.com. Diltiazem. http://www.drugs.com/pro/diltiazem.html. Accessed Feb 3, 2016.Drugs.com. Diltiazem. http://www.drugs.com/pro/diltiazem.html. Accessed Feb 3, 2016., Drugs.com. Diltiazem. http://www.drugs.com/pro/diltiazem.html. Accessed Feb 3, 2016.
F. Angeli, P. Verdecchia, G. Reboldi, R. Gattobigio, M. Bentivoglio, J. Staessen, C. Porcellati (2004)
Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.American journal of hypertension, 17 9
S. Glasser, T. Gana, L. Pascual, K. Albert (2005)
Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.American heart journal, 149 2
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, T. Jaarsma, P. Kirchhof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad (2007)
2013 ESH/ESC Guidelines for the management of arterial hypertensionBlood Pressure, 22
W. Frishman, S. Charlap, B. Kimmel, Mark Teicher, J. Cinnamon, L. Allen, J. Strom (1988)
Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.Circulation, 77 4
W. White, Y. Lacourciére, T. Gana, M. Pascual, David Smith, K. Albert (2004)
Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.American heart journal, 148 4
(2013)
2013 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens, 31
D. Johnston, R. Lesoway, D. Humen, W. Kostuk (1985)
Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.The American journal of cardiology, 55 6
Cardiol Ther (2016) 5:75–82 DOI 10.1007/s40119-016-0059-1 ORIGINAL RESEARCH Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases . . . Luis Rodrı´guez Padial Gonzalo Baro´n-Esquivias Antonio Herna´ndez Madrid . . Domingo Marzal Martı´n Vicente Pallare´s-Carratala´ Alejandro de la Sierra Received: February 10, 2016 / Published online: March 25, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com Abstract: Cardiovascular diseases are the Diltiazem, a non-dihydropyridine calcium leading cause of death in the world. Coronary channel blocker, is an effective and safe artery diseases, atrial fibrillation or hypertensive antihypertensive drug, alone or in combination heart disease, are among the most important with other agents. Diltiazem lowers myocardial cardiovascular disorders. Hypertension oxygen demand through a reduction in heart represents a significant risk factor for rate, blood pressure, and cardiac contractility, cardiovascular mortality; thus, control of high representing also a good alternative for the blood pressure has become a priority to prevent treatment of stable chronic angina. major complications. Although the choice of Furthermore, diltiazem reduces conduction in drugs for treating hypertension remains atrioventricular node, which is also useful for controversial, extensive clinical evidences point heart rate control in patients with atrial to calcium channel blockers as
Cardiology and Therapy – Springer Journals
Published: Mar 25, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.